Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Stivarga
Pharma
Takeda, Hutchmed hook up on cancer drug for $1.13B
Takeda has gained commercial rights to Hutchmed's cancer drug fruquintinib outside of China for $400M up front, plus $730M in potential milestones.
Kevin Dunleavy
Jan 23, 2023 10:31am
Servier, Taiho's Lonsurf excels in colorectal cancer upgrade
Jan 18, 2023 3:50pm
ESMO: Eyeing Bayer, Hutchmed touts 'practice-changing' CRC win
Sep 7, 2022 6:30pm
Bayer poaches GSK exec to lead oncology business
Feb 7, 2022 10:39am
Bayer's post-Xarelto, post-Eylea life is better than expected
Mar 10, 2021 12:22pm
Bayer looks for pharma growth as new drugs start to take shape
Feb 25, 2021 11:53am
